6505--Tacrolimus Capsules
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79726R0033
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents2
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued a solicitation for the supply of Tacrolimus Capsules. This procurement, identified by Solicitation Number 36E79726R0033, seeks to secure a reliable source for the manufacturing and delivery of pharmaceutical-grade Tacrolimus Capsules, a critical immunosuppressive medication widely used in transplant medicine and other clinical applications within the VA healthcare system.
The scope of this solicitation encompasses the manufacturing, packaging, and timely delivery of Tacrolimus Capsules in accordance with all applicable federal regulations and quality standards. The intended outcome is to ensure uninterrupted access to this essential medication for veterans receiving care through VA medical facilities nationwide. Contractors are expected to demonstrate robust capabilities in pharmaceutical preparation manufacturing, as classified under NAICS Code 325412 (Pharmaceutical Preparation Manufacturing, 2022 version), and must adhere to the stringent requirements associated with Product Service Code 6505 (Drugs and Biologicals).
Key requirements for this procurement include the consistent production of high-quality Tacrolimus Capsules that meet all U.S. Food and Drug Administration (FDA) standards, as well as VA-specific quality assurance protocols. Prospective contractors should be prepared to provide comprehensive documentation of their manufacturing processes, quality control measures, and supply chain reliability. Deliverables will likely include regular shipments of the medication, detailed batch records, and compliance with all labeling, packaging, and distribution requirements as specified in the solicitation documents.
The contracting activity is managed by the NAC Pharmaceuticals office, a federal entity within the Department of Veterans Affairs. The primary point of contact for this opportunity is Christopher Carthron, who can be reached via email at [email protected] for further information or clarification regarding the solicitation.
This is a formal solicitation (active as of April 9, 2026), and interested parties are required to submit their responses by September 16, 2026. The opportunity is posted on SAM.gov, where additional attachments related to the solicitation are available for review. Contractors should carefully examine all provided documentation to ensure full compliance with the stated requirements.
No specific set-aside requirements or special considerations are indicated in the available information; however, all interested contractors must be capable of meeting the rigorous standards expected by the Department of Veterans Affairs for pharmaceutical supply contracts. This opportunity represents a significant and ongoing need within the VA system, and contractors with proven experience in pharmaceutical manufacturing and distribution are encouraged to evaluate their alignment with the solicitation’s objectives and requirements.